US team finds Parkinson's risk factor
This article was originally published in Clinica
Executive Summary
In what could pave the way to a screening test for Parkinson's disease, US researchers have identified a biomarker for the disorder. The researchers found that high levels of MAO-B, an enzyme that regulates nerve activity in the brain, cause Parkinsonian symptoms in mice. The research could lead to earlier diagnosis and hence treatment of the condition, which could help slow disease progression, claimed the researchers, based at the Buck Institute for Age Research, in Novato, California. The findings are published in the February 20 issue of online Journal PLoS One.
You may also be interested in...
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.